Scholar Rock (SRRK)

• Market cap: $4.4B
• 1 day: -1.95%
• 5 days: -5.95%
• 1 month: -4.56%
• 3 months: 44.34%
• 6 months: 16.28%
• Year to date: 0.77%
• 1 year: 1.87%
• 5 years: -25.24%
• 10 years: 178.26%
• Sector: Healthcare
• Industry: Biotechnology

About: Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Employees: 196